178 related articles for article (PubMed ID: 20488818)
21. Apolipoprotein A-I mimetic peptides.
Van Lenten BJ; Wagner AC; Anantharamaiah GM; Navab M; Reddy ST; Buga GM; Fogelman AM
Curr Atheroscler Rep; 2009 Jan; 11(1):52-7. PubMed ID: 19080728
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.
Navab M; Anantharamaiah GM; Hama S; Garber DW; Chaddha M; Hough G; Lallone R; Fogelman AM
Circulation; 2002 Jan; 105(3):290-2. PubMed ID: 11804981
[TBL] [Abstract][Full Text] [Related]
24. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice.
Wool GD; Cabana VG; Lukens J; Shaw PX; Binder CJ; Witztum JL; Reardon CA; Getz GS
FASEB J; 2011 Jan; 25(1):290-300. PubMed ID: 20876212
[TBL] [Abstract][Full Text] [Related]
25. Effects of genotype and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I-, and apolipoprotein E-deficient mice.
Huang Y; Zhu Y; Langer C; Raabe M; Wu S; Wiesenhütter B; Seedorf U; Maeda N; Assmann G; von Eckardstein A
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2010-9. PubMed ID: 9351366
[TBL] [Abstract][Full Text] [Related]
26. Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice.
Bruneval P; Bariéty J; Bélair MF; Mandet C; Heudes D; Nicoletti A
Nephrol Dial Transplant; 2002 Dec; 17(12):2099-107. PubMed ID: 12454219
[TBL] [Abstract][Full Text] [Related]
27. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A-I promotes cholesterol release and apolipoprotein E recruitment from THP-1 macrophage-like foam cells.
Bielicki JK; McCall MR; Forte TM
J Lipid Res; 1999 Jan; 40(1):85-92. PubMed ID: 9869653
[TBL] [Abstract][Full Text] [Related]
29. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Wagner AC; Hama S; Hough G; Bachini E; Garber DW; Mishra VK; Palgunachari MN; Fogelman AM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1932-7. PubMed ID: 15961700
[TBL] [Abstract][Full Text] [Related]
30. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
Spangenberg J; Curtiss LK
Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
[TBL] [Abstract][Full Text] [Related]
31. Potential clinical utility of high-density lipoprotein-mimetic peptides.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
[TBL] [Abstract][Full Text] [Related]
33. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.
Woo JM; Lin Z; Navab M; Van Dyck C; Trejo-Lopez Y; Woo KM; Li H; Castellani LW; Wang X; Iikuni N; Rullo OJ; Wu H; La Cava A; Fogelman AM; Lusis AJ; Tsao BP
Arthritis Res Ther; 2010; 12(3):R93. PubMed ID: 20482780
[TBL] [Abstract][Full Text] [Related]
34. Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts.
Hsieh GR; Schnickel GT; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplantation; 2007 Jul; 84(2):238-43. PubMed ID: 17667816
[TBL] [Abstract][Full Text] [Related]
35. New kids on the block: the emerging role of apolipoproteins in the pathogenesis and treatment of asthma.
Yao X; Remaley AT; Levine SJ
Chest; 2011 Oct; 140(4):1048-1054. PubMed ID: 21972383
[TBL] [Abstract][Full Text] [Related]
36. Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses.
Kobayashi Y; Inagawa H; Kohchi C; Kazumura K; Tsuchiya H; Miwa T; Okazaki K; Soma GI
PLoS One; 2018; 13(3):e0195008. PubMed ID: 29584779
[TBL] [Abstract][Full Text] [Related]
37. Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity.
Madenspacher JH; Azzam KM; Gong W; Gowdy KM; Vitek MP; Laskowitz DT; Remaley AT; Wang JM; Fessler MB
J Biol Chem; 2012 Dec; 287(52):43730-40. PubMed ID: 23118226
[TBL] [Abstract][Full Text] [Related]
38. Comparison of human apoA-I expression in mouse models of atherosclerosis after gene transfer using a second generation adenovirus.
Tsukamoto K; Hiester KG; Smith P; Usher DC; Glick JM; Rader DJ
J Lipid Res; 1997 Sep; 38(9):1869-76. PubMed ID: 9323596
[TBL] [Abstract][Full Text] [Related]
39. Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.
Yao X; Gordon EM; Figueroa DM; Barochia AV; Levine SJ
Am J Respir Cell Mol Biol; 2016 Aug; 55(2):159-69. PubMed ID: 27073971
[TBL] [Abstract][Full Text] [Related]
40. High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice.
Cai X; Ahmad G; Hossain F; Liu Y; Wang X; Dennis J; Freedman B; Witting PK
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
